title: Impact of OKT3 treatment for steroid resistant rejection of renal allografts: the long-term outcome at a single center.
authors.affiliation: Department of Urology, Tokyo Women's Medical University, Japan.
authors.forename: M
authors.initials: M
authors.lastname: Inui
authors.forename: K
authors.initials: K
authors.lastname: Tanabe
authors.forename: N
authors.initials: N
authors.lastname: Ishikawa
authors.forename: T
authors.initials: T
authors.lastname: Tokumoto
authors.forename: M
authors.initials: M
authors.lastname: Harano
authors.forename: S
authors.initials: S
authors.lastname: Otsubo
authors.forename: K
authors.initials: K
authors.lastname: Suzuki
authors.forename: N
authors.initials: N
authors.lastname: Goya
authors.forename: T
authors.initials: T
authors.lastname: Yagisawa
authors.forename: H
authors.initials: H
authors.lastname: Nakazawa
authors.forename: S
authors.initials: S
authors.lastname: Fuchinoue
authors.forename: H
authors.initials: H
authors.lastname: Toma
mesh_terms: D000206:Actuarial Analysis; D000208:Acute Disease; D000328:Adult; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D003404:Creatinine / Q000097:blood; D004351:Drug Resistance; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000188:drug therapy* / Q000453:epidemiology; D006085:Graft Survival; D006146:Guanidines / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology / Q000401:mortality / Q000502:physiology*; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D016853:Muromonab-CD3 / Q000627:therapeutic use*; D012189:Retrospective Studies; D016019:Survival Analysis; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D000961:Antilymphocyte Serum; D006146:Guanidines; D007166:Immunosuppressive Agents; D016853:Muromonab-CD3; D003404:Creatinine; C037258:gusperimus; D008775:Methylprednisolone